Visit Us On TwitterVisit Us On FacebookVisit Us On YoutubeVisit Us On Linkedin
Active ImplantsActive Implants
Active Implants
Knee Replacement Options and Meniscus Pain Relief
  • About Us
    • About Us
    • News & Events
      • Press Releases
      • News Coverage
      • Events
    • Management Team
    • Board of Directors
    • Careers
  • NUsurface®
    • https://activeimplants.com/tramadol-brand-names/
  • https://activeimplants.com/tenuate-vs-adipex/
    • https://activeimplants.com/dapoxetine-reviews/
    • purchase levitra online
    • Treatment Options
  • Medical Professionals
    • NUsurface® Clinical Trials
    • Publications
  • Contact Us
  • Blog
  • About Us
    • About Us
    • News & Events
      • Press Releases
      • News Coverage
      • Events
    • Management Team
    • Board of Directors
    • Careers
  • NUsurface®
    • https://activeimplants.com/tramadol-brand-names/
  • https://activeimplants.com/tenuate-vs-adipex/
    • https://activeimplants.com/dapoxetine-reviews/
    • purchase levitra online
    • Treatment Options
  • Medical Professionals
    • NUsurface® Clinical Trials
    • Publications
  • Contact Us
  • Blog

Press Releases

09/06/21

Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis

07/15/21

Two-Year Data from MERCURY Study Presented at AOSSM-AANA Combined 2021 Annual Meeting

11/16/19

World’s First “Artificial Meniscus” Available in Israel

09/19/19

Active Implants Receives FDA Breakthrough Device Designation for NUsurface® Meniscus Implant

07/20/18

Final Patient Treated in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant

08/09/17

100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant

08/02/17

Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface® Meniscus Implant

07/12/17

Active Implants LLC Appoints Charles W. Federico and Gary D. Henley to Board of Managers

07/06/17

TOCA (The Orthopedic Clinic Association) Performs First Meniscus Replacements in Arizona with NUsurface® Meniscus Implant

06/27/17

OrthoIndy Performs First Meniscus Replacements in Indiana with NUsurface® Implant

06/07/17

Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

05/23/17

OrthoMemphis Performs First Meniscus Replacement in Tennessee with NUsurface® Implant

05/01/17

Advanced Orthopedics & Sports Medicine Specialists Performs First
Meniscus Replacements in Colorado with NUsurface® Meniscus Implant

03/16/17

Active Implants LLC Secures First Tranche of a $40 Million Equity Financing

02/22/17

Active Implants Appoints Ted Davis President and Chief Executive Officer

02/09/17

Arlington Orthopedic Associates, P.A. Performs First Meniscus Replacements in Texas with NUsurface® Meniscus Implant

10/17/16

Capital Regional Orthopaedic Associates Performs First Meniscus Replacements in New York with NUsurface® Implant

09/07/16

Sports Medicine Oregon Performs First Meniscus Replacements in Oregon with NUsurface® Implant

06/13/16

Baton Rouge Orthopaedic Clinic Performs First Meniscus Replacement in the South with NUsurface® Implant

05/29/16

Salt Lake Regional Medical Center First in the U.S. to Perform Meniscus Replacement to Relieve Persistent Knee Pain in SUN Clinical Trial

03/08/16

Advanced Orthopaedics Performs Virginia’s First Meniscus Replacement with NUsurface® Implant

02/09/16

Active Implants’ VENUS Clinical Trial for Persistent Knee Pain Now Underway in Memphis

02/03/16

VENUS Clinical Trial for Persistent Knee Pain Now Underway in North Carolina

02/02/16

Active Implants Initiates Second Clinical Trial Evaluating NUsurface® Meniscus Replacement

11/24/15

VENUS Clinical Trial for Persistent Knee Pain Now Underway in Indiana

11/09/15

VENUS Clinical Trial for Persistent Knee Pain Now Underway in New York City

01/26/15

First NUsurface® Meniscus Implant Implanted in the US for Early Knee Osteoarthritis

05/29/14

U.S. Food & Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to conduct a pivotal clinical trial of the NUsurface® Meniscus Implant for early Knee Osteoarthritis

09/03/13

Active Implants LLC Closes $26.0 Million Financing Round

01/07/13

NUsurface® Meniscus Clinical Trial Reaches Key Milestone

12/03/12

Active Implants Corporation Announces Appointment of New President

01/09/12

$10 MM Convertible Debt to Focus on Clinical Study

09/01/09

Active Implants Announces CE Class III Medical Device Approval

06/30/09

Active Implants Corporation Names New Chief Financial Officer

06/03/09

Active Implants Corporation Closes $10 Million in Financing and Announces New Board Director

10/21/08

Active Implants Enters Agreement with UK Company

09/15/08

Active Implants, InMotion Forge New Partnership Relationship Expands Active Implants Research Capabilities In Advanced Polymers In Orthopedics

09/18/06

Active Implants Corporation Announces CE Mark Approval for Novel Low Wear, Polymer Hip Implant

09/05/06

Active Implants Corporation Announces Vice President Orthopedic Research

04/10/06

Active Implants(TM) Corporation Clinicals Begin on Innovative, Polymer Hip Implant;

Early Intervention Orthopedic Company Reaches $10 million Funding Milestone

07/18/05

Active Implants Corporation Announces Funding Milestone and Creation of Board and Management Team

  • View All
  • Events
  • News Coverage
  • Press Releases

© 2022 Active Implants. 6060 Primacy Parkway Suite 460 Memphis, TN 38119901.762.0352Privacy Policy     EU Website: www.activeimplants.eu